CodeBreaK 100/101: First report of safety/efficacy of sotorasib in combination with pembrolizumab or atezolizumab in advanced KRAS p.G12C NSCLC Meeting Abstract


Authors: Li, B. T.; Falchook, G. S.; Durm, G. A.; Burns, T. F.; Skoulidis, F.; Ramalingam, S. S.; Spira, A.; Bestvina, C. M.; Goldberg, S. B.; Veluswamy, R.; Iams, W. T.; Chiappori, A. A.; Lemech, C. R.; Meloni, A. R.; Ebiana, V.; Dai, T.; Gauto, D. M.; Varrieur, T. L.; Snyder, W. J.; Govindan, R.
Abstract Title: CodeBreaK 100/101: First report of safety/efficacy of sotorasib in combination with pembrolizumab or atezolizumab in advanced KRAS p.G12C NSCLC
Meeting Title: 2022 World Conference on Lung Cancer
Journal Title: Journal of Thoracic Oncology
Volume: 17
Issue: 9 Suppl.
Meeting Dates: 2022 Aug 6-9
Meeting Location: Vienna, Austria
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2022-09-01
Start Page: S10
End Page: S11
Language: English
DOI: 10.1016/j.jtho.2022.07.025
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: OA03.06 -- Located within section named "OA03 Molecular Targeted Treatments" -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bob Tingkan Li
    278 Li